Using various models of amyloid pathology, conflicting results have been reported regarding the impact of both CD4+ and CD8+ T cells, infiltrating the brain, on disease progression, suggesting both beneficial and detrimental impacts [45, 46]. The gene discussed is CD4; the disease is amyloidosis.